Cenovus Energy Inc. CVE

Zacks Investment Research 13 nov

Cenovus Energy (CVE) is well-positioned for long-term growth supported by its expanding oil sands operations with declining unit costs and ambitious production targets. The company aims to reach 1.1 million barrels of oil equivalent per day by 2028, driven by projects like the Christina Lake North expansion. CVE trades at a valuation discount to industry peers and has received upward earnings revisions.

Zacks Investment Research 11 nov

Imperial Oil (IMO) has gained 42.8% year-to-date, outperforming the broader energy sector. The company is positioned for long-term growth through higher production targets at Kearl (300,000 bpd by 2028) and Cold Lake (165,000 bpd), lower operating costs, favorable refining margins, and expanding renewable diesel operations. With C$3.2B in Q3 operating cash flow, 32 consecutive years of dividend growth, and strong shareholder returns, IMO is rated a Zacks Rank #2 (Buy) with 2026 earnings estimates showing 100.8% year-over-year growth.

Zacks Investment Research 10 nov

Cenovus Energy (CVE) has outperformed peers and the S&P 500 with a 63.1% year-to-date gain, driven by 23% production growth, declining operating costs, and multiple expansion projects targeting 1.1 million BOE/d by 2028. Analysts have raised 2026 earnings estimates by 21.35% and 2027 estimates by 47.78%, while the stock trades at a valuation discount (4.04X EV/EBITDA) compared to industry peers.

Zacks Investment Research 9 nov

Cenovus Energy is strengthening refining margins through expanded market access via the Laurel pipeline and Toledo dock investments. The company achieved an 88% adjusted market capture rate in Q3 2026. Marathon Petroleum and Phillips 66 are also pursuing refining optimization and infrastructure investments to improve profitability and access higher-value markets.

GlobeNewswire Inc. 9 nov

Cenovus Energy Inc. announced the Toronto Stock Exchange has approved the renewal of its normal course issuer bid (NCIB) to repurchase up to 126,482,982 common shares over a 12-month period starting November 11, 2026. The company repurchased 88.3 million shares under its prior NCIB at a weighted-average price of $38.35 per share. All shares acquired under the renewed NCIB will be cancelled.